Simple Search Results

Didn't find what you were looking for? Try the Advanced Search »

Search Again »

Abstract Number: 1707 • 2015 ACR/ARHP Annual Meeting
Comorbidity Burden and Medication Use Among Patients with Psoriatic Arthritis in the US
Joseph F. Merola¹, Simeng Han², Jipan Xie², Huaying Song², Vivian Herrera³, Jin Wei², Eric Q. Wu² and Jacqueline B. Palmer³, ¹Brigham and Women's Hospital, Boston, MA, ²Analysis Group, Inc., Boston, MA, ³Novartis Pharmaceuticals Corporation, East Hanover, NJ
Background/Purpose: Psoriatic arthritis (PsA) is a chronic inflammatory disease that is associated with various comorbidities. This study aimed to assess the comorbidity burden and medication…
Abstract Number: 1813 • 2015 ACR/ARHP Annual Meeting
Novel Mechanism of Action of Anti-Malarial Drugs in the Inhibition of Type I Interferon Production
Jie An¹, Joshua Woodward², Mark Minie³, YuFeng Peng⁴, Tomikazu Sasaki⁵ and Keith B. Elkon⁶, ¹Division of Rheumatology, Department of Medicine & Immunology, University of Washington, Seattle, WA, ²Department of Microbiology, University of Washington, Seattle, WA, ³Department of Bioengineering, University of Washington, Seattle, WA, ⁴Rheumatology, University of Washington, Seattle, WA, ⁵Department of Chemistry, University of Washington, Seattle, WA, ⁶Department of Medicine & Immunology, University of Washington, Seattle, WA
Background/Purpose: Anti-malarial drugs (AMD) such as Hydroxychloroquine (HCQ) and Quinacrine (QC) are effective in the treatment of skin rash and arthritis in systemic lupus erythematosus…
Abstract Number: 1998 • 2015 ACR/ARHP Annual Meeting
A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR’s Rheumatology Informatics System for Effectiveness (RISE)
Jinoos Yazdany¹, Rachel Myslinski², Melissa Francisco³, Nick Bansback⁴, Megan E. B. Clowse⁵, Deborah Collier⁶, Karen Law⁷, Katherine Liao⁸, Kaleb Michaud⁹, Esi Morgan-DeWitt¹⁰, Jim Oates¹¹, Catalina Orozco¹², Andreas Reimold¹³, Julia F Simard¹⁴ and Salahuddin Kazi¹⁵, ¹University of California, San Francisco, San Francisco, CA, ²Governance & Ethics Specialist, Amer College of Rheumatology, Atlanta, GA, ³Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, ⁴Population and Public Health, The University of British Columbia, Vancouver, BC, Canada, ⁵Clinical Rheumatologist, Duke University Medical Center, Durham, NC, ⁶Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁷Emory University School of Medicine, Atlanta, GA, ⁸Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, ⁹Rheumatology & Immunology, University of Nebraska Medical Center and National Data Bank, Omaha, NE, ¹⁰Pediatric rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹¹Medicine, Medical University of South Carolina, Charleston, SC, ¹²Arthritis Consultation Ctr, Dallas, TX, ¹³Rheumatology, VAMC, University of Texas Southwestern Medical Center, Dallas, TX, ¹⁴Division of Epidemiology, Health Research and Policy Department, and Division of Immunology & Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, ¹⁵Internal Medicine/Rheumatology, UT Southwestern Medical Center, Dallas, TX
Title: A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR's Rheumatology Informatics System for Effectiveness (RISE)Background/Purpose: In 2014, the ACR launched the Rheumatology Informatics…
Abstract Number: 2109 • 2015 ACR/ARHP Annual Meeting
Racial Disparities in the Risk of Hospitalized Severe Allopurinol Hypersensitivity Syndrome – a US Nationwide Study (2009-2011)
Na Lu¹, Sharan K. Rai², Jeewoong Choi³ and Hyon K. Choi¹, ¹Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ²Experimental Medicine, University of British Columbia, Vancouver, BC, Canada, ³Massachusetts College of Pharmacy and Health Sciences, Boston, MA
Background/Purpose: Allopurinol is the leading choice of urate-lowering therapy for gout (>95% of treated cases); however, it is associated with the rare but potentially fatal…
Abstract Number: 2222 • 2015 ACR/ARHP Annual Meeting
Teaching Rheumatology in Undergraduate Medical Education: What Are the Students Saying?
Amy C. Cannella¹, Gerald F. Moore², Ted R. Mikuls³, James R. O'Dell³, Sarah B. McBrien⁴, Michelene Hearth-Holmes², Lynell W. Klassen², Marcus H. Snow², Michael G. Feely², Zachary D. Fowler⁵, Maxwell Burchell⁵ and Alan R. Erickson⁶, ¹Divison of Rheumatology, University of Nebraska College of Medicine and VA Nebraska Western Iowa Health Care System, Omaha, NE, ²Division of Rheumatology, University of Nebraska College of Medicine and VA Nebraska Western Iowa Health Care System, Omaha, NE, ³University of Nebraska Medical Center, Omaha, NE, ⁴Educational Support Office, University of Nebraska College of Medicine, Omaha, NE, ⁵College of Information Science and Technology, University of Nebraska at Omaha, Omaha, NE, ⁶University of Nebraska College of Medicine and VA Nebraska Western Iowa Health Care System, Omaha, NE
Background/Purpose: At the University of Nebraska College of Medicine (COM), rheumatology is taught in a block to second year medical students (M2s). The educational content…
Abstract Number: 2236 • 2015 ACR/ARHP Annual Meeting
Global Prevalence of Hyperuricemia: A Systematic Review of Population-Based Epidemiological Studies
Emma Smith¹ and Lyn March², ¹Department of Rheumatology, Northern Clinical School, Institute of Bone and Joint Research, Kolling Institute, University of Sydney & Department of Rheumatology, Royal North Shore Hospital, St. Leonards, Sydney, Australia, ²Department of Rheumatology, Northern Clinical School, Institute of Bone and Joint Research, Kolling Institute, University of Sydney & Department of Rheumatology, Royal North Shore Hospital, St Leonards, Sydney, Australia
Background/Purpose: Hyperuricemia, or raised serum uric acid (SUA), is the condition closely associated with gout due to the deposition of monosodium urate crystals in peripheral…
Abstract Number: 2237 • 2015 ACR/ARHP Annual Meeting
Effects of Coffee Consumption on Serum Uric Acid. a Systematic Review and Meta-Analysis
Jae-Bum Jun¹, Shin-Young Yim², Hyun Jung Kim³, Kyu Yong Park⁴, Hyeong Sik Ahn³, Sun Hee Kim⁴ and Eun Ji Park⁴, ¹Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ²Department of Physical Medicine and Rehabilitation, Ajou University School of Medicine, Suwon, South Korea, ³Department of Preventive Medicine, Korea University College of Medicine, Seoul, South Korea, ⁴Department of Physical Medicine and Rehabilitation, Ajou University Hospital, Suwon, South Korea
Background/Purpose: Findings on the effect of coffee consumption on serum uric acid has been conflicting. The aim of this systematic review and meta-analysis is to analyze…
Abstract Number: 2238 • 2015 ACR/ARHP Annual Meeting
Body Mass Index Modulates the Relationship Between Sugar-Sweetened Beverage Intake and Serum Urate Concentration
Nicola Dalbeth¹, Amanda Phipps-Green², Meaghan House¹, Gregory Gamble¹, Anne Horne¹, Lisa K. Stamp³ and Tony R. Merriman^2,4, ¹Department of Medicine, University of Auckland, Auckland, New Zealand, ²University of Otago, Dunedin, New Zealand, ³Medicine, University of Otago, Christchurch, Christchurch, New Zealand, ⁴Biochemistry Dept, PO Box 56, University of Otago, Dunedin, New Zealand
Background/Purpose: Elevated body mass index (BMI) and intake of sugar-sweetened beverages (SSB) are both modifiable risk factors for hyperuricaemia and gout. BMI can modulate the…
Abstract Number: 2240 • 2015 ACR/ARHP Annual Meeting
Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate: A Study Using Large Intergrated National Health Network
Jasvinder A. Singh¹, Shuo Yang², S. Louis Bridges Jr.³ and Kenneth G. Saag⁴, ¹Birmingham VAMC, Birmingham, AL, ²Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁴University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: To comprehensively assess patient, comorbidity, physician, system, health care access and disease factors associated with the ability to achieve and maintain target serum urate…
Abstract Number: 2254 • 2015 ACR/ARHP Annual Meeting
Socio-Economically Deprived Patients Have a Higher Likelihood for Having Any Type of Rheumatic and Musculoskeletal Diseases and Have Higher Healthcare Costs – Results from a Population-Based Administrative Database Including 1.9 Million Persons (Basque country, Spain)
Polina Putrik¹, Sofia Ramiro², Jon Orueta³, Edurne Alonso Moran⁴, Roberto Nuno Solinis⁵ and Annelies Boonen⁶, ¹Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ²Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ³Centro de Salud de Astrabudua, Osakidetza, Basque Health Service, Erandio, Spain, ⁴O+berri, Basque Institute for Healthcare Innovation, Barakaldo, Spain, ⁵Universidad Deusto, Bilbao, Spain, ⁶Maastricht University Medical Center, Maastricht, Netherlands
Background/Purpose: Rheumatic and musculoskeletal diseases (RMDs) are prevalent and have a strong impact on health care costs. Some evidence in specific diseases indicates that patients…
Abstract Number: 2265 • 2015 ACR/ARHP Annual Meeting
Prevalence and Physical and Mental Health Patterns of Rheumatic and Musculoskeletal Diseases in Portugal: Results from a National Health Survey
Jaime C Branco¹, Ana M. Rodrigues², Nelia Gouveia³, Leonor P Costa⁴, Monica Eusebio⁵, Sofia Ramiro^2,4,6, Pedro Machado^4,7,8, Filipa Mourão^4,9,10, Inês Silva^9,11, Pedro Laires⁴, Alexandre Sepriano^4,12, Filipe Araújo^4,13, Sónia Gonçalves⁴, Pedro S Coelho^4,14, Viviana Tavares⁴, Jorge Cerol^4,15, Jorge M Mendes^4,14, Loreto Carmona¹⁶ and Helena Canhao¹⁷, ¹NOVA Medical School/faculdade de ciências médicas, Universidade Nova de Lisboa, Lisboa, Portugal, ²CEDOC - Chronic Diseases FCM NOVA, NOVA Medical School - Faculdade de Ciências Médicas da UNL, Lisbon, Portugal, ³CEDOC - Chronic Diseases FCM NOVA, NOVA Medical School - Faculdade Ciências Médicas da UNL, Lisbon, Portugal, ⁴EpiReumaPt Study Group, Lisbon, Portugal, ⁵Portuguese Society of Rheumatology, Lisbon, Portugal, ⁶Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁷Clínica Universitária de Reumatologia, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, ⁸University College London - MRC Centre for Neuromuscular Diseases,, London, United Kingdom, ⁹Centro Hospitalar Lisboa Ocidental (CHLO- E.P.E.), Lisbon, Portugal, ¹⁰NOVA Medical School - Faculdade Ciências Médicas da Universidade Nova de Lisboa, Lisbon, Portugal, ¹¹EpiReumaPt Study Group, lisbon, Portugal, ¹²Rheumatology, Hospital de Egas Moniz - CHLO, Lisbon, Portugal, Lisbon, Portugal, ¹³Rheumatology, Centro Hospitalar de Lisboa Ocidental, Hospital Egas Moniz, Lisboa, Portugal, ¹⁴NOVA Information Management School, Lisbon, Portugal, ¹⁵Portuguese Catholic University, Lisbon, Portugal, ¹⁶Instituto de Salud Musculoesquelética, Madrid, Spain, ¹⁷Hospital Santa Maria - Serviço de Reumatologia, Lisboa, Portugal
Background/Purpose: Rheumatic and musculoskeletal diseases (MSKD) are a prevalent leading cause of disability and consume a large amount of healthcare and social resources. MSKD have been…
Abstract Number: 2271 • 2015 ACR/ARHP Annual Meeting
Does Arthritis in the Young Adult Life Phase Impact Involvement in Transitional Social Roles?
Arif Jetha^1,2, Kristina Theis³ and Michael Alden Boring³, ¹Center for Disability Research, Liberty Mutual Research Institute for Safety, Hopkinton, MA, ²Institute for Work & Health, Toronto, ON, Canada, ³Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: Post-secondary schooling and/or obtaining employment are milestones of a successful transition to adulthood. It is unclear if young adults, ages 18 to 29 years,…
Abstract Number: 2279 • 2015 ACR/ARHP Annual Meeting
Impacts on Work: Arthritis Vs Chronic Joint Symptoms without Arthritis
Kristina A. Theis and Michael Boring, Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: While chronic joint symptoms are characteristic of arthritis, previous studies have shown that many people with chronic joint symptoms do not have doctor-diagnosed arthritis.…
Abstract Number: 2283 • 2015 ACR/ARHP Annual Meeting
Current and Lifetime Smoking Among US Adults with Arthritis: A Serious Clinical and Public Health Issue
Louise Murphy¹, Miriam G. Cisternas² and Teresa J. Brady¹, ¹Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ²MGC Data Services, Carlsbad, CA
Background/Purpose: Smoking's adverse effects include increased risk of joint replacement failure and decreased medication effectiveness (e.g., methotrexate, TNF blockers). Because little is known about the…
Abstract Number: 2327 • 2015 ACR/ARHP Annual Meeting
Documentation of Clinical Improvement in Patient with Polymyalgia Rheumatica According to MDHAQ/RAPID3 (Multidimensional Health Assessment Questionnaire/Routine Assessment of Patient Index Data): Longitudinal Analysis from Routine Care
Isabel Castrejón¹, Annie Huang¹, Sarah L. Everakes², Ailda Nika¹, Winston Sequeira¹ and Theodore Pincus¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Internal Medicine, Rush University Medical Center, Chicago, IL
Background/Purpose: RAPID3 is an index found on the MDHAQ, which is effective in rheumatoid arthritis (RA) clinical trials and clinical care (1). MDHAQ/RAPID3 also is…

Search Again »

Didn't find what you were looking for? Try the Advanced Search »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].